SCHEMBL12713655

SCHEMBL12713655

CNC(=O)OCCCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29016409 0.86
SCHEMBL12172818 0.85 EPHX1 (0.71)
SCHEMBL14067802 0.83 EPHX1 (0.83)
SCHEMBL10817551 0.83 EPHX1 (0.83)
SCHEMBL10812052 0.83 EPHX1 (0.83)
SCHEMBL10812071 0.83 EPHX1 (0.83)
SCHEMBL10817110 0.83 EPHX1 (0.83)
SCHEMBL16541245 0.80 CHRNB2 (0.65)
SCHEMBL20661311 0.79
SCHEMBL968307 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248832-A1 Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy UNIV EMORY (US) 2023-08-10 US disclosed
US-10723760-B2 Method for preparing site-specifically modified protein based on novel carbon-carbon bond formation KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2020-07-28 US disclosed
WO-2018044130-A1 NOVEL METHOD FOR PRODUCING PROTEIN HAVING A CARBON-CARBON BOND-BASED SITE-SPECIFIC MODIFICATION 한국과학기술원 2018-03-08 WO disclosed
US-20180066011-A1 METHOD FOR PREPARING SITE-SPECIFICALLY MODIFIED PROTEIN BASED ON NOVEL CARBON-CARBON BOND FORMATION PROMEDIGEN (KR) 2018-03-08 US disclosed
US-20160310604-A1 SMALL MOLECULE LIGAND-DRUG CONJUGATES FOR TARGETED CANCER THERAPY CEDARS-SINAI MEDICAL CENTER 2016-10-27 US disclosed
US-20160310604-A1 SMALL MOLECULE LIGAND-DRUG CONJUGATES FOR TARGETED CANCER THERAPY CEDARS-SINAI MEDICAL CENTER 2016-10-27 US disclosed
US-20110085974-A1 SMALL MOLECULE LIGAND-DRUG CONJUGATES FOR TARGETED CANCER THERAPY CEDARS-SINAI MEDICAL CENTER (US) 2011-04-14 US disclosed